Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Cardiovascular Development and Disease is Scopus-indexed (Q1, CiteScore 4.5), WoS SCIE, DOAJ. Published by Multidisciplinary Digital Publishing Institute (MDPI).
Checked against the index lists dated .
ISSN 2308-3425Verify ISSN ↗
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (all) | 19 / 79 | 76th | Q1 |
| Pharmacology (medical) | 116 / 278 | 58th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2014–present, best quartile Q1, CiteScore 4.5.
Journal of Cardiovascular Development and Disease is Q1 in Pharmacology, Toxicology and Pharmaceutics (all) (rank 19 of 79) and Q2 in Pharmacology (medical) (rank 116 of 278), by CiteScore 2025.
Journal of Cardiovascular Development and Disease is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.5, which places it in quartile Q1 at the 76th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.758, quartile Q1, with an H-index of 43.
The publisher lists an article processing charge of about US$3,258 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Cardiovascular Development and Disease is published by Multidisciplinary Digital Publishing Institute (MDPI). Its ISSN is 2308-3425.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Journal of Cardiovascular Development and Disease has an h-index of 53 and a 2-year mean of 2.45 citations per paper (OpenAlex). Its Scopus CiteScore is 4.5, quartile Q1. On 2-year citations it ranks #23 of 77 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (all).
Journal of Cardiovascular Development and Disease published 509 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2026), authors are most often from China (26.8%), United States (17.2%) and Türkiye (15.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.